How does HBV interact with the immune system? | Robert Thimme, MD

International Workshop on HBV Cure 2016

Why do we need new treatments and what is our definition of cure? | Harry Janssen, MD, PhD

International Workshop on HBV Cure 2016

Virological Approach - New Nucleoside Analogue & Capsid inhibition | Fabien Zoulim, MD, PhD

International Workshop on HBV Cure 2016

Virological Approach - Small interfering RNA’s | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)

International Workshop on HBV Cure 2016

Virological Approach - CCC – DNA inhibition | Massimo Levrero, MD

International Workshop on HBV Cure 2016

Virological Approach - Entry inhibition | Stephan Urban, PhD

International Workshop on HBV Cure 2016

Current Status of HBV Therapy | Pietro Lampertico, MD, PhD

International Workshop on HBV Cure 2016

Russian HIV Clinical Series | Roundtable Discussion | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Virological Approach - Assembly and Secretion Inhibitors | Tim Block, PhD

International Workshop on HBV Cure 2016

The Mycobiome and How it Influences Disease | Mahmoud Ghannoum, PhD, MBA

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

The “Window of Opportunity”: Harnessing the Pediatric Immune Landscape for Life-Long Vaccine- Elicited Protection | Sallie Permar, MD, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

The Human Microbiome and Cancer: New Opportunities For Population Studies | Emily Vogtmann, PhD, MPH

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

The NIH’s human microbiome project | Lita Proctor, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Live Biotherapeutics: How the Vaginal Microbiome Can be Modified to Prevent HIV Infection | Laurel Lagenaur, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Functional Role of Gut Microbiota in Chronic Liver Disease | Gary Wu, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Key note: Systems Biology, Modeling, and Cross-Meta-Omic Analysis of the Human Microbiome | Elhanan Borenstein, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Zika Neuropathies Beyond Microcephaly | Maurício Lacerda Nogueira, MD, PhD

HIV DART and Emerging Viruses 2016

Global Burden and Novel Treatment of Noroviruses | Ladislau Kovari, PhD

HIV DART and Emerging Viruses 2016

State of the Art Lecture: What Do We Really Know About Dengue Viruses | Oscar Perng, PhD

HIV DART and Emerging Viruses 2016

HIV Knowledge and Hope in Africa | Carol A. Harris, MD

HIV DART and Emerging Viruses 2016

Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH

HIV DART and Emerging Viruses 2016

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

HIV DART and Emerging Viruses 2016

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

HIV DART and Emerging Viruses 2016

HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhD

HIV DART and Emerging Viruses 2016